Fennec Pharmaceuticals Inc.
FENC· Nasdaq
Fennec Pharmaceuticals Inc.
- Last sale
- Oct 1, 2026 · -2.82%
- Market cap
- $362.24M
- 35.07M shares
- Filings
- 842
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $44,642,000 | reported | |
| FY 2024 | 2024-12-31 | $47,538,000 | reported | |
| FY 2023 | 2023-12-31 | $21,252,000 | reported | |
| FY 2022 | 2022-12-31 | $1,535,000 | reported | |
| FY 2019 | 2020-12-31 | $200,000 | reported | |
| FY 2018 | 2018-12-31 | $0 | reported | |
| FY 2017 | 2017-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $0 | reported | |
| FY 2015 | 2015-12-31 | $0 | reported | |
| FY 2014 | 2014-12-31 | $0 | reported | |
| FY 2013 | 2013-12-31 | $0 | reported |
Fennec Pharmaceuticals Inc. · CIK 1211583 · Engraved from SEC EDGAR
